Mochida Pharmaceutical Future Growth
Future criteria checks 3/6
Mochida Pharmaceutical is forecast to grow earnings and revenue by 22.5% and 2.8% per annum respectively. EPS is expected to grow by 22.8% per annum. Return on equity is forecast to be 5.3% in 3 years.
Key information
22.5%
Earnings growth rate
22.8%
EPS growth rate
Pharmaceuticals earnings growth | 20.6% |
Revenue growth rate | 2.8% |
Future return on equity | 5.3% |
Analyst coverage | Low |
Last updated | 05 Feb 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 110,000 | 7,400 | 5,605 | N/A | 1 |
3/31/2026 | 108,000 | 6,650 | 4,917 | N/A | 1 |
3/31/2025 | 106,000 | 5,900 | 3,666 | N/A | 1 |
3/31/2024 | 102,000 | 4,400 | N/A | N/A | 1 |
12/31/2023 | 100,085 | 3,012 | N/A | N/A | N/A |
9/30/2023 | 99,537 | 5,564 | -6,181 | -3,807 | N/A |
6/30/2023 | 100,316 | 5,182 | N/A | N/A | N/A |
3/31/2023 | 103,261 | 6,649 | 5,131 | 7,297 | N/A |
12/31/2022 | 106,759 | 8,470 | N/A | N/A | N/A |
9/30/2022 | 109,370 | 9,576 | 6,374 | 9,742 | N/A |
6/30/2022 | 110,509 | 11,071 | N/A | N/A | N/A |
3/31/2022 | 110,179 | 10,569 | 4,471 | 7,459 | N/A |
12/31/2021 | 107,928 | 10,360 | N/A | N/A | N/A |
9/30/2021 | 105,381 | 8,092 | 6,937 | 9,076 | N/A |
6/30/2021 | 102,978 | 7,873 | N/A | N/A | N/A |
3/31/2021 | 102,995 | 8,587 | 7,263 | 9,198 | N/A |
12/31/2020 | 102,583 | 6,627 | N/A | N/A | N/A |
9/30/2020 | 101,910 | 5,417 | 8,375 | 10,452 | N/A |
6/30/2020 | 102,690 | 4,660 | N/A | N/A | N/A |
3/31/2020 | 101,799 | 4,598 | 7,389 | 9,347 | N/A |
12/31/2019 | 101,102 | 4,964 | N/A | N/A | N/A |
9/30/2019 | 103,919 | 6,091 | 8,803 | 10,474 | N/A |
6/30/2019 | 106,331 | 5,897 | N/A | N/A | N/A |
3/31/2019 | 109,643 | 8,435 | 11,197 | 12,565 | N/A |
12/31/2018 | 110,669 | 9,602 | N/A | N/A | N/A |
9/30/2018 | 109,409 | 10,037 | 4,989 | 6,046 | N/A |
6/30/2018 | 107,550 | 10,548 | N/A | N/A | N/A |
3/31/2018 | 106,761 | 9,023 | 2,188 | 3,283 | N/A |
12/31/2017 | 108,042 | 8,001 | N/A | N/A | N/A |
9/30/2017 | 105,511 | 8,886 | N/A | 3,100 | N/A |
6/30/2017 | 101,852 | 9,569 | N/A | N/A | N/A |
3/31/2017 | 97,349 | 8,526 | N/A | 5,583 | N/A |
12/31/2016 | 93,140 | 9,547 | N/A | N/A | N/A |
9/30/2016 | 93,337 | 8,897 | N/A | 11,870 | N/A |
6/30/2016 | 94,138 | 8,226 | N/A | N/A | N/A |
3/31/2016 | 92,272 | 8,150 | N/A | 15,211 | N/A |
12/31/2015 | 92,138 | 9,449 | N/A | N/A | N/A |
9/30/2015 | 90,200 | 9,262 | N/A | 11,072 | N/A |
6/30/2015 | 89,467 | 8,823 | N/A | N/A | N/A |
3/31/2015 | 87,252 | 7,544 | N/A | 5,122 | N/A |
12/31/2014 | 89,529 | 7,881 | N/A | N/A | N/A |
9/30/2014 | 91,037 | 8,585 | N/A | 9,248 | N/A |
6/30/2014 | 92,015 | 9,872 | N/A | N/A | N/A |
3/31/2014 | 93,947 | 9,892 | N/A | 12,478 | N/A |
12/31/2013 | 92,291 | 10,171 | N/A | N/A | N/A |
9/30/2013 | 90,902 | 8,404 | N/A | 11,441 | N/A |
6/30/2013 | 90,220 | 8,418 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MFY's forecast earnings growth (22.5% per year) is above the savings rate (0.6%).
Earnings vs Market: MFY's earnings (22.5% per year) are forecast to grow faster than the German market (15.1% per year).
High Growth Earnings: MFY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MFY's revenue (2.8% per year) is forecast to grow slower than the German market (5.5% per year).
High Growth Revenue: MFY's revenue (2.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MFY's Return on Equity is forecast to be low in 3 years time (5.3%).